Savers Value Village (SVV) General Counsel Executes 20,000-Share Sale Under 10b5-1
Rhea-AI Filing Summary
Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), reported transactions on 09/26/2025. He exercised or acquired 20,000 shares of common stock at an exercise price of $1.41 and simultaneously sold 20,000 shares under a 10b5-1 plan at a weighted average price of $13.6905 (execution prices ranged from $13.48 to $13.87). After these transactions the reporting person shows 0 shares of common stock directly owned.
Table II shows derivative holdings of options representing the right to purchase common stock at $1.41 with 364,256 shares underlying reported as beneficially owned. The filing notes that certain options are time-based (approximately 12%) and performance-based (approximately 88%), with vesting and performance conditions described for the 2019 grant.
Positive
- Sale executed under a 10b5-1 plan, indicating pre-arranged trading and reduced concerns about opportunistic timing
- Weighted average sale price disclosed ($13.6905) with price range ($13.48–$13.87) and offer to provide per-price details, enhancing transparency
- Detailed vesting disclosure for the 2019 option grant, including time-based (~12%) and performance-based (~88%) splits
Negative
- Reporting person holds 0 direct common shares after transactions, which reduces immediate insider equity alignment with shareholders
- Significant number of performance-based options (≈88%) remain subject to future conditions, creating uncertainty about eventual dilution timing
Insights
TL;DR: Insider exercised and sold the same number of shares via a 10b5-1 plan, retaining substantial option exposure.
Medway exercised or acquired 20,000 shares at a nominal exercise price of $1.41 and sold those 20,000 shares under a 10b5-1 plan at a weighted average of $13.6905, realizing monetization while recording zero direct common shares after the sale. The filing discloses 364,256 option-based shares outstanding to the reporting person, comprised of time- and performance-based grants from a 2019 plan. For investors this indicates insider liquidity activity without reduction in option-based upside exposure; the sale was pre-planned under a 10b5-1 arrangement and the weighted average sale price range is disclosed.
TL;DR: Transaction appears routine and compliant; sale executed under a pre-established 10b5-1 plan.
The report explicitly states the sale was made pursuant to a 10b5-1 plan adopted March 10, 2025, and provides the weighted average sale price range with an offer to supply per-price execution details to regulators or shareholders. The option grant details and vesting schedules from June 12, 2019 are disclosed, including the split between time-based and performance-based awards. This level of disclosure supports compliance and transparency around insider trades and option vesting conditions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 20,000 | $1.41 | $28K |
| Exercise | Common Stock | 20,000 | $1.41 | $28K |
| Sale | Common Stock | 20,000 | $13.6905 | $274K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.48 to $13.87. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. Approximately 12% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 88% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
